1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 20 JULY 2015

CNS Drug News 20 JULY 2015

  • July 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Newly Approved Rexulti Will Need To Be Differentiated From Predecessor Abilify
Industry Brief - Biotie Starts Tozadenant Phase III Study In PD
Industry Brief - Aurobindo Gains US Entacapone Approval
Industry Brief - Adamas Completes Recruitment Of ADS-5102 Phase III Study For PD-Associated LID
Industry Trend Analysis - Actavis' Grip On Namenda Market To Diminish
Industry Brief - CereSpir Obtains US Patent Covering Commercial Manufacture Of CSP-1103
Industry Brief - Cytokinetics Starts Phase III Trial Of Tirasemtiv In ALS
Industry Brief - FDA Grants ODD To C2N/AbbVie's C2N-8E12 For PSP
Industry Brief - EC Approves Vanda's Hetlioz For Non-24
Industry Brief - Ferrer Initiates Phase IIa Study Of Lorediplon In Insomnia
Industry Brief - SDP/Servier Partner On Latuda In Australia
Industry Brief - Saphris 2.5mg Tablets Available At Pharmacies Throughout US
Industry Trend Analysis - Abuse-Deterrent Formulations Will Increase Spend On Opioids
Industry Brief - Allergan To Acquire Worldwide Rights To Merck's CGRP Migraine Development Programme
Industry Brief - Teva Launches Almotriptan In US
Industry Brief - Fycompa Launched In UK For PGTC Seizures
Industry Trend Analysis - Resubmitted Sustol Will Be Growth Driver In CINV Drugs Market
Industry Brief - FDA Grants ODD To Newron's Sarizotan For Rett Syndrome
Industry Trend Analysis - Horizon Will Need To Raise Offer For Depomed
Industry Brief - Eisai To Transfer North Carolina Plant To Biogen
Industry Trend Analysis - Receptos Acquisition Will Enhance Celgene's Blockbuster Autoimmune Expectations
Industry Brief - Highland Forms US Commercial Subsidiary
Industry Brief - CNS Conferences - October 2015

Table Of Contents

CNS Drug News 20 JULY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Alcoholism and drug dependence and addiction, known as substance use disorders and rehabilitation treatments are classified as substance abuse treatment. Some of the common symptoms of drug abuse are ...

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • August 2016
  • by Industry ARC

Psychotherapeutic drugs are used to treat mental illnesses such as extreme mood swings, social withdrawal, long lasting depression, confused thinking, and suicidal thought. schizophrenia, bipolar disorder, ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.